Cannapharmarx, Inc. (CPMD): Total Liabilities
$37.17M
As of 2025-12-31
$37.72M
As of 2026-06-30
+17.8%
3-year compound annual growth
+16.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $37.17M | +21.3% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $30.65M | +28.2% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $23.90M | +5.0% | 2025-04-10, Balance as of period end |
| 2022-12-31 | $22.76M | +74.5% | 2023-09-01, Balance as of period end |
| 2021-12-31 | $13.04M | -25.7% | 2023-09-01, Balance as of period end |
| 2020-12-31 | $17.55M | +57.2% | 2022-04-15, Balance as of period end |
| 2019-12-31 | $11.16M | +7.5% | 2021-04-14, Balance as of period end |
| 2018-12-31 | $10.38M | +976.9% | 2020-05-27, Balance as of period end |
| 2017-12-31 | $964.3K | +0.5% | 2019-04-03, Balance as of period end |
| 2016-12-31 | $959.3K | +37.7% | 2018-09-14, Balance as of period end |
| 2015-12-31 | $696.6K | -66.6% | 2018-09-14, Balance as of period end |
| 2014-12-31 | $2.09M | +614.1% | 2018-09-11, Balance as of period end |
| 2013-12-31 | $292.0K | n/a | 2015-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $37.17M | +21.3% |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $128.86M | +21.9% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.10M | +34.7% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $28.89M | +7.5% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $2.42M | -6.4% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $13.04M | -6.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.59M | +24.9% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $4.11M | -57.1% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $5.05M | -18.9% |
Compare CPMD, NWBO, ATXI, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗